It’s about time: The association between abacavir and cardiovascular disease
Antiviral Therapy · 2026-04 · 31 (2)
DOI: 10.1177/13596535261438178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antiviral Therapy, online erschienen am 24.04.2026. Verfasst von Jim Young und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Dideoxynucleosides, Cardiovascular Diseases, Anti-HIV Agents, HIV Infections. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Data from the REPRIEVE trial have been used to study the association between treatment with abacavir and cardiovascular disease in people with HIV. Past exposure to abacavir before the trial was found to be just as risky as exposure during the trial. This calls into doubt the widely accepted hypothesis that recent exposure to abacavir increases the risk of cardiovascular disease but that risk rapidly attenuates after exposure ends. The evidence for this hypothesis is weak while evidence for an alternative hypothesis has been neglected. An alternative hypothesis is that risk from exposure to abacavir is not immediate but increases as exposure cumulates, plateauing after about three years. Confusion over the likely effect of abacavir has arisen partly because overly simplistic methods have been used to model the exposure outcome relationship in observational cohort data. Better methods are available and should be used in future to avoid misdirected research effort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
- Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
- Division of Clinical Epidemiology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.
ORCID-Profile: Jim Young, Patrick R Lawler, Erica E M Moodie, Heiner C Bucher, Marina B Klein
Zitieren
APA
Young, J., Lawler, P. R., Moodie, E. E. M., Bucher, H. C., & Klein, M. B. (2026). It’s about time: The association between abacavir and cardiovascular disease. Antiviral Therapy, 31(2). https://doi.org/10.1177/13596535261438178
Vancouver
Young J, Lawler PR, Moodie EEM, Bucher HC, Klein MB. It’s about time: The association between abacavir and cardiovascular disease. Antiviral Therapy. 2026;31(2). doi:10.1177/13596535261438178
BibTeX
@article{Young2026,
author = {Young, Jim and Lawler, Patrick R and Moodie, Erica E M and Bucher, Heiner C and Klein, Marina B},
title = {It’s about time: The association between abacavir and cardiovascular disease},
journal = {Antiviral Therapy},
year = {2026},
volume = {31},
number = {2},
doi = {10.1177/13596535261438178}
}
EUVIMED